peoplePerson
Amar U. Kishan
Radiation oncologist who showed MRI-guided prostate radiotherapy causes fewer side effects.
Radiation oncologist leading MIRAGE, the randomised trial of MRI-guided versus CT-guided prostate SBRT, and pooled analyses of androgen deprivation with radiotherapy.
Role
Professor and Vice Chair of Clinical and Translational Research, Radiation Oncology, UCLA
Institution
Specialisms
Prostate radiotherapyMR-guided radiotherapyHypofractionation
Profiles
Pages like this
not linked directly; found by shared links- PairingAI pathology → androgen deprivation duration
Shares ArteraAI Prostate, Prostate cancer.
- PersonJeremie Calais
Shares UCLA Jonsson Comprehensive Cancer Center, Prostate cancer.
- ProductDecipher Prostate
Shares ArteraAI Prostate, Prostate cancer.
- CompanyArtera
Shares ArteraAI Prostate, Prostate cancer.
- PersonJohannes Czernin
Shares UCLA Jonsson Comprehensive Cancer Center, Prostate cancer.
- ProductGallium-68 gozetotide (PSMA-11)
Shares UCLA Jonsson Comprehensive Cancer Center, Prostate cancer.
- InstitutionUMC Utrecht Cancer Center
Shares MR-guided adaptive radiotherapy, SBRT / SABR (stereotactic radiotherapy), Prostate cancer.
- InstitutionHokkaido University Hospital
Shares SBRT / SABR (stereotactic radiotherapy), Prostate cancer.